FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lubiprostone submitted by Dr. Reddy's Laboratories, updating labeling under NDA 021908.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation
• Irritable Bowel Syndrome with Constipation
• Opioid-induced Constipation

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

SUPPL AP for LUBIPROSTONE (LUBIPROSTONE)